HKSE - Delayed Quote • HKD
Innovent Biologics, Inc. (1801.HK)
At close: 4:09 PM GMT+8
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Chen (Kaixian) Independent Non-Executive Director | Other | Jan 31, 2022 | 4,702 |
| Cooney (Charles Leland) Independent Non-Executive Director | Other | Jan 31, 2022 | 39,118 |
| Ede (Hao Xi) Chief Financial Officer | Sale | Jul 22, 2021 | 3,815,616 |
| Hsu Joyce I-Yin Independent Non-Executive Director | Other | Jan 31, 2022 | 4,702 |
| Yu (De-Chao Michael) Chief Executive Officer | Other | Jan 31, 2022 | 105,899,908 |
Related Tickers
1877.HK Shanghai Junshi Biosciences Co., Ltd.
10.240
+5.24%
6160.HK BeiGene, Ltd.
90.000
+3.45%
9688.HK Zai Lab Limited
12.640
+2.10%
9926.HK Akeso, Inc.
48.450
+2.11%
2269.HK WuXi Biologics (Cayman) Inc.
12.740
-1.24%
9995.HK RemeGen Co., Ltd.
30.250
+2.89%
1952.HK Everest Medicines Limited
24.100
+2.55%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
153.900
-0.06%
2162.HK Keymed Biosciences Inc.
34.950
+3.86%
6855.HK Ascentage Pharma Group International
17.300
+0.46%